CERS2 and liver cancer: The findings of the transwell migration and matrigel invasion assays revealed that LASS2 overexpression resulted in a lower migration and invasion capability compared with the negative control or vector-control cells in the liver cancer cell lines (all P < 0.01, Fig. 1D–G and Fig. S1D–F).